PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22266871-0	2012	Inhibition of Gli1 results in altered c-Jun activation, inhibition of cisplatin-induced upregulation of ERCC1, XPD and XRCC1, and inhibition of platinum-DNA adduct repair.	Cisplatin	70-79	X-ray repair cross complementing 1	Homo sapiens	119-124	
22266871-3	2012	We therefore studied the possible relationships between Gli1, c-jun, and the upregulation of ERCC1, XPD and XRCC1 in cisplatin-resistant human ovarian cancer cells.	Cisplatin	117-126	X-ray repair cross complementing 1	Homo sapiens	108-113	
22266871-8	2012	Use of the anti-Gli1 shRNA in cisplatin-resistant cells resulted in a block of the cell"s ability to upregulate genes in response to cisplatin treatment, including: c-jun, ERCC1, XPD and XRCC1.	Cisplatin	30-39	X-ray repair cross complementing 1	Homo sapiens	187-192	
22266871-8	2012	Use of the anti-Gli1 shRNA in cisplatin-resistant cells resulted in a block of the cell"s ability to upregulate genes in response to cisplatin treatment, including: c-jun, ERCC1, XPD and XRCC1.	Cisplatin	133-142	X-ray repair cross complementing 1	Homo sapiens	187-192